CDC News: Deputy Director Shuford to Leave After Midterms

Jennifer Shuford, the deputy director and chief medical officer of the Centers for Disease Control and Prevention, is leaving the Trump administration after only six months in the job, she confirmed to The Washington Post late on Monday night. The latest cdc news comes a week before the midterm elections, and Shuford is expected to leave the agency after voters go to the polls on November 3, according to people familiar with the situation. Her departure removes one of the most experienced public health voices from an agency that has already lost its director once this year, and it renews questions about the administration’s direction on vaccine policy at a moment when the president is pushing for changes to childhood vaccination.

Shuford, an infectious-disease physician who had served as health commissioner of Texas, was hired in April as part of a new four-person leadership team tapped to run the CDC and restore confidence in the agency, Trump officials said at the time. Her exit, after such a short tenure, is the second high-profile departure from the top of the agency in less than a year, and it comes after a series of developments that have renewed questions about how the administration is handling vaccines. The Post had previously reported her planned departure, according to three people who spoke on condition of anonymity to discuss a sensitive personnel matter, and Shuford confirmed it herself in a statement on Monday night.

CDC News: Why Shuford Is Leaving

“I am leaving to spend more time with my family,” Shuford said in her statement. “I am so thankful to President Trump and Secretary Kennedy for giving me the opportunity to help lead CDC. It has been an amazing experience, and I will be forever grateful for it.” The statement was warm, and it gave no hint of disagreement with the administration she is leaving. But the reasons for her departure are not settled, and the people who described it to the Post gave different accounts.

One person attributed the decision to a health matter in her family, while another said she had disagreed with the administration’s approach to vaccine policy. That second account, if correct, would place her departure in the middle of the most contentious debate in American public health: the administration’s push to change the way children are vaccinated, and the role of the CDC in setting the guidance that doctors, insurers, and state health officials rely on. Neither the CDC nor the White House has confirmed the departure, and Reuters said it could not immediately verify the report, which was based on the Post’s sourcing.

Shuford is expected to leave after next week’s midterm elections, according to two of the people familiar with the situation. The timing is notable: it means she will stay through the vote on November 3, and leave in the days that follow. It also means her departure will not be announced as a formal resignation until the election is over, which avoids a public health leadership story in the final days of a campaign in which the administration’s handling of vaccines and public health has been a point of attack for Democrats.

Vaccine News: The Policy Fight Behind the Departure

The vaccine debate that appears to lie behind Shuford’s departure has been building since the start of the administration. Kennedy, who has advanced claims linking vaccines to autism, has made changing childhood vaccination a central goal of his time as health secretary. Extensive scientific research has found no such connection between vaccines and autism, and the claim has been repeatedly debunked by scientists. But the administration has pressed ahead, and the CDC, as the country’s main public health agency, has been at the centre of the argument over what guidance the government gives to parents and doctors.

Shuford’s background made her an unusual figure in that debate. She is an infectious-disease physician with a long career in public health, and she came to the CDC from Texas, where she had been the state’s health commissioner. CDC scientists had been optimistic about her hiring because of her public health background and her willingness to speak out about the measles outbreak in Texas last year, even as Kennedy, the nation’s top public health official, has played down measles outbreaks. Career staff at the agency told the Post that her appointment was a sign that the administration was serious about restoring the agency’s credibility.

The contrast between Shuford and Kennedy on measles was public and sharp. This week, Kennedy said that measles outbreaks are “not unusual.” But as Texas state health commissioner, Shuford had explained the outbreak in her own state in very different terms, saying, “this outbreak is unusual for Texas, we haven’t had this sort of an outbreak since the early 1990’s.” That difference, between a health secretary who minimised the outbreak and a state health commissioner who warned about it, was one of the reasons CDC scientists welcomed her arrival in April. It is also, according to one of the Post’s sources, one of the reasons she is now leaving.

Public Health News: A Leadership Team Built in April

Shuford was not hired alone. She arrived in April as part of a wave of senior hires that the administration presented as a fresh start for the CDC. The group included Erica Schwartz, a former deputy surgeon general who became the agency’s director, Sean Slovenski, who came from the healthcare industry, and Sara Brenner, who had worked at the Food and Drug Administration. The four were tapped to run the agency and restore confidence in it, after a year in which the CDC’s credibility had been badly damaged.

The damage came from the top. Last year, Health Secretary Kennedy clashed with the CDC’s then-leader, Susan Monarez, over vaccine policy and forced her out after less than one month in the job. Monarez’s ouster sparked bipartisan backlash and questions about whether the agency could be trusted to shape vaccine policy and other United States public health efforts. It was one of the most public ruptures between a health secretary and the agency he oversees, and it left the CDC’s leadership in disarray.

Shuford and the administration’s other recent hires, including CDC Director Erica Schwartz, have worked to tamp down those concerns since April. Their job was to show that the agency could still function as a credible source of public health guidance, even as the administration’s vaccine policy moved in a direction that many scientists opposed. Shuford’s departure after six months suggests that the effort has not held together, and that the tension between the agency’s scientific staff and the administration’s political leadership remains unresolved.

The CDC, based in Atlanta, is the country’s main public health agency and plays a central role in issuing vaccine guidance used by doctors, insurers, and state health officials across the United States. As chief medical officer, Shuford has been one of the agency’s most senior clinical voices, and her role was to give that guidance scientific authority. Her exit, whatever the reason, removes a layer of that authority at a moment when the agency is under pressure to change the guidance it gives.

Health News: What the Departure Means for Vaccine Policy

The immediate question is what happens to the vaccine policy that Shuford is said to have disagreed with. The president’s proposal to split certain childhood vaccinations into five separate doses is a shift in line with a goal long promoted by Kennedy, and it would change the way the CDC’s childhood immunisation schedule is put together. The proposal has not been adopted as policy, but the administration’s push for it has continued, and Shuford’s departure removes one of the people who might have resisted it from inside.

The longer question is about the CDC itself. The agency has now lost two of its most senior leaders in less than a year, one forced out after less than a month and one leaving after six months. The four-person leadership team that was supposed to restore confidence in the agency has lost one of its members before the midterm elections, and the agency’s director, Erica Schwartz, is now left to run it without her deputy and chief medical officer. That is a difficult position for any agency, and it is a particularly difficult one for an agency whose job is to give the public clear, trusted guidance on health.

Shuford’s own statement gave no hint of any of this. She thanked the president and the health secretary, and said she was leaving to spend more time with her family. That may be the whole story, or it may be only part of it. The people who spoke to the Post gave two accounts, and the truth may lie somewhere between them: a family health matter and a disagreement over policy are not mutually exclusive, and a six-month tenure at the top of a troubled agency is enough to test anyone’s patience.

What Happens Next

The next step is for the administration to say who will replace Shuford, and whether the replacement will share her background in public health or her willingness to speak out about outbreaks. The CDC’s deputy director and chief medical officer is not a ceremonial role: it is the person who gives the agency’s guidance its clinical authority, and who speaks for its scientists when the guidance is challenged. Whoever fills it will inherit the same tensions that Shuford faced, between an administration that wants to change vaccine policy and an agency whose scientists believe the evidence points the other way.

The timing of the announcement will also matter. Shuford is expected to leave after the midterm elections, which means the formal announcement may not come until next week. Until then, the CDC will continue to operate with a leadership team that is already one person short, and the questions about the agency’s direction on vaccines will remain unanswered.

For the public, the practical question is simpler: whether the guidance that doctors and parents rely on will change, and whether the agency that issues it can still be trusted. Shuford’s departure does not answer that question, but it makes it harder to ignore. A six-month tenure at the top of the CDC, ending a week before an election, is a sign of an agency under strain, and the strain is not going away.

Source: The Washington Post